Adding free to total prostate-specific antigen levels in trials of prostate cancer screening

We used a nested case–control design on data from men in four prospective studies (from the UK, Maryland in the USA, and two from Finland) with available stored serum samples to determine whether there was an advantage in measuring both free prostate-specific antigen (PSA) and total PSA as a potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wald, N J, Watt, H C, George, L, Knekt, P, Helzlsouer, K J, Tuomilehto, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363306/
https://www.ncbi.nlm.nih.gov/pubmed/10682690
http://dx.doi.org/10.1054/bjoc.1999.0988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363306/
https://www.ncbi.nlm.nih.gov/pubmed/10682690
http://dx.doi.org/10.1054/bjoc.1999.0988

Ejemplares similares